The CDC has updated its guidance as to who is at risk for more severe cases of coronavirus disease 2019 (COVID-19); Texas suspended its economic reopening in the wake of surging COVID-19 cases; HHS releases updated organ donation rules.
The CDC broadened its warning about who is at risk for developing more severe coronavirus disease 2019 (COVID-19) symptoms, STAT News reports. The new guidance suggests younger individuals who are obese or have underlying health conditions can also be at risk of serious complications from COVID-19, in addition to the elderly and older individuals with underlying conditions. CDC Director Robert Redfield, MD, recently noted that although 6% of the American population has been tested for COVID-19, for every person who tests positive there is likely another 10 individuals who have gone undiagnosed.As COVID-19 cases continue to surge in southern and western regions of the United States, the governor of Texas, Gregg Abbott (R) announced the state’s reopening would be halted, according to Reuters. On Monday, the state reported 6000 new cases in a single day—one of the biggest jumps in new cases to date. The temporary pause is intended to corral the spread of COVID-19, Abbott explained. Meanwhile, Texas had reported record numbers of hospitalizations for 13 days in a row, and elective surgeries have been suspended in Houston, Dallas, Austin, and San Antonio hospitals to reserve beds for COVID-19 patients. HHS announced new solid organ transplant guidance with the aim of assessing donors and recipients for human immunodeficiency virus (HIV), hepatitis B, and hepatitis C infections. As over 110,000 patients in the United States are currently waiting for an organ transplant, the guidance takes into account advances in transplant technology and safety so as to increase the number of organs available. In the past, organs have been declined because of concerns about potential infections of the diseases. New highly accurate tests have facilitated quick determinations as to whether an organ donor is infected, thus reducing the risk for getting these infections from a transplant.
DLBCL Outcomes Vary Sharply for Patients 80 Years and Older
April 16th 2025A majority of cases of diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma globally, are diagnosed in patients 65 years and older; these patients are a heterogeneous group, and few studies have investigated how their outcomes are influenced by patient characteristics and care management regimens.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Complete Responses Seen With Emerging Therapies for Chronic Spontaneous Urticaria
April 16th 2025There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who are difficult to treat.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More